ATE309265T1 - Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt - Google Patents

Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt

Info

Publication number
ATE309265T1
ATE309265T1 AT00946023T AT00946023T ATE309265T1 AT E309265 T1 ATE309265 T1 AT E309265T1 AT 00946023 T AT00946023 T AT 00946023T AT 00946023 T AT00946023 T AT 00946023T AT E309265 T1 ATE309265 T1 AT E309265T1
Authority
AT
Austria
Prior art keywords
peptide compound
reading frame
open reading
compound derived
ice gene
Prior art date
Application number
AT00946023T
Other languages
English (en)
Inventor
Christophe Ronsin
Veronique Scott
Frederic Triebel
Original Assignee
Roussy Inst Gustave
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Roussy Inst Gustave filed Critical Roussy Inst Gustave
Application granted granted Critical
Publication of ATE309265T1 publication Critical patent/ATE309265T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14—Hydrolases (3)
    • C12N9/16—Hydrolases (3) acting on ester bonds (3.1)
    • C12N9/18—Carboxylic ester hydrolases (3.1.1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/461—Cellular immunotherapy characterised by the cell type used
    • A61K39/4611—T-cells, e.g. tumor infiltrating lymphocytes [TIL], lymphokine-activated killer cells [LAK] or regulatory T cells [Treg]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/46—Cellular immunotherapy
    • A61K39/464—Cellular immunotherapy characterised by the antigen targeted or presented
    • A61K39/4643—Vertebrate antigens
    • A61K39/4644—Cancer antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2799/00—Uses of viruses
    • C12N2799/02—Uses of viruses as vector
    • C12N2799/021—Uses of viruses as vector for the expression of a heterologous nucleic acid

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Wood Science & Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Biotechnology (AREA)
  • Cell Biology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oncology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
AT00946023T 1999-06-28 2000-06-27 Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt ATE309265T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
FR9908224A FR2795415B1 (fr) 1999-06-28 1999-06-28 Compose peptidique derive d'une orf decalee du gene ice
PCT/FR2000/001791 WO2001000784A2 (fr) 1999-06-28 2000-06-27 COMPOSE PEPTIDIQUE DERIVE D'UNE ORF DECALEE DU GENE iCE

Publications (1)

Publication Number Publication Date
ATE309265T1 true ATE309265T1 (de) 2005-11-15

Family

ID=9547371

Family Applications (1)

Application Number Title Priority Date Filing Date
AT00946023T ATE309265T1 (de) 1999-06-28 2000-06-27 Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt

Country Status (9)

Country Link
US (1) US6875844B1 (de)
EP (1) EP1192179B1 (de)
JP (1) JP2003503042A (de)
AT (1) ATE309265T1 (de)
AU (1) AU5992500A (de)
CA (1) CA2377433A1 (de)
DE (1) DE60023891T2 (de)
FR (1) FR2795415B1 (de)
WO (1) WO2001000784A2 (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004111075A2 (en) * 2003-03-05 2004-12-23 Dendreon Corporation Alternative reading frame polypeptides for treatment
EP2044949A1 (de) 2007-10-05 2009-04-08 Immutep Verwendung von rekombinantem LAG-3 oder Derivaten daraus zur Auslösung einer Monozyten-Immunreaktion
CN104630149B (zh) * 2013-11-08 2018-08-21 中国科学院广州生物医药与健康研究院 外源线粒体导入到哺乳动物细胞中的方法
GB201322626D0 (en) 2013-12-19 2014-02-05 Immutep S A Combined preparations for the treatment of cancer
GB201500374D0 (en) 2015-01-09 2015-02-25 Immutep S A Combined preparations for the treatment of cancer
WO2018035311A1 (en) * 2016-08-19 2018-02-22 Gray John T Compositions and methods for modulating gene expression using reading frame surveillance

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000505650A (ja) * 1996-02-08 2000-05-16 アメリカ合衆国 樹状突起細胞を形質転換し、そしてｔ細胞を活性化するための方法及び組成物
AU7724398A (en) * 1997-06-06 1998-12-21 Regents Of The University Of California, The A melanoma associated antigen, t cell epitopes thereof and methods of using sa me
DE69837273T2 (de) * 1997-10-08 2008-01-31 The Government Of The United States Of America As Represented By The Secretary, Department Of Health And Human Services Menschliches krebsantigen ny eso-1/cag-3 und dazu kodierendes gen

Also Published As

Publication number Publication date
WO2001000784A2 (fr) 2001-01-04
EP1192179A2 (de) 2002-04-03
WO2001000784A3 (fr) 2001-07-26
JP2003503042A (ja) 2003-01-28
FR2795415A1 (fr) 2000-12-29
DE60023891T2 (de) 2006-07-27
US6875844B1 (en) 2005-04-05
FR2795415B1 (fr) 2003-09-05
AU5992500A (en) 2001-01-31
CA2377433A1 (fr) 2001-01-04
EP1192179B1 (de) 2005-11-09
DE60023891D1 (de) 2005-12-15

Similar Documents

Publication Publication Date Title
ATE185572T1 (de) Kombinatorische pna-bibliotheken und verbesserte syntheseverfahren
BG104819A (en) Substituted indolealkanoic acids
WO1999024460A3 (en) Dipeptide nitriles
CY1109450T1 (el) Μεθοδοι παρασκευης πεπτιδιων
ID21956A (id) Asam n-(aril dan atau heteroarilasetil) amino ester, komposisi farmasi yang mengandungnya, dan metoda untuk menghambat pelepasan betha-amiloid peptida dan atau sintesanya dengan menggunakan senyawa tersebut
EP1276756A1 (de) Albumin fusionsproteine
CY1107552T1 (el) Ly6h γονιδιο
AU2001264515A1 (en) Melphalan derivatives and their use as cancer chemotherapeutic drugs
WO2001083774A3 (en) Novel mutated form of arginine deiminase
MA26487A1 (fr) Heterocyclecetohydrazides inhibiteurs de proteases, procede pour leur preparation et compositions pharmaceutiques les contenant .
NO20001556L (no) Kontrastmidler for infarkt- og nekroseavbildning
ATE309265T1 (de) Peptidverbindung, die von einem verschobenen offenen leserahmen des ice-gens abstammt
WO2004074454A3 (en) Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
FR2744455B1 (fr) Nouvelles sequences d'acides nucleiques de la famille des facteurs suppresseurs de tumeurs, produits d'expression correspondants et leurs applications
DE69808475T2 (de) Aminosäurederivate zur behandlung von schlaganfall
HUP0100277A3 (en) 2,3,4,5-tetrahydro-1h-[1,4]-benzodiazepine-3-hydroxamic acids as metalloproteinase inhibitors, process for their preparation and pharmaceutical compositions containing them
WO2003040290A3 (de) Gene aus corynebacterium glutamicum die fuer homeostase- und adaptions-proteine codieren
TW200517125A (en) Pharmaceutical composition for treatment of solid cancers
BG107553A (en) Aminoalkenylbenzoyl-benzofuran or benzothiophene derivatives, methods for preparing same and compositions containing same
WO2001092468A3 (en) Novel compositions for the expression of the human peptide histidine transporter 1 and methods of use thereof
WO1997046672A3 (en) Antisense nucleic acids and hammerhead ribozymes
WO2002029054A1 (fr) Nouvelle proteine, son procede de production et son utilisation
WO2004078921A3 (en) Methods and compositions for the treatment of cancer and infectious disease using alpha (2) macroglobulin-antigenic molecule complexes
WO2001089281A3 (de) Tumorassoziiertes antigen (b132), charakterisiert durch seq. id. no. 2
WO2002034901A3 (en) Protein kinase

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification

Ref document number: 1192179

Country of ref document: EP

REN Ceased due to non-payment of the annual fee